InsiderClue
← All stocks

ARS Pharmaceuticals, Inc.

SPRY Net buying
CIK 0001671858 #3013 in the set updated 19 Sep 2026
Bought (120 mo)
$109.79M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$121.40M
$47.85M on a plan · $23.16M straight out of an exercise
Sold at will
$50.39M
23 of 223 sales
Net
−$11.62M
+$59.39M against sales at will

By person

25 insiders · 261 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$44.72M (6)
—
+$44.72M
9,958,073
$99.58M
—
Lowenthal Richard E
PRESIDENT AND CEO
—
$23.82M (73) scheduled
−$23.82M
5,523,683
$55.24M
—
Flynn James E
10% owner
—
$23.81M (10)
−$23.81M
4,887,254
$48.87M
−21.1%
Tanimoto Sarina
CHIEF MEDICAL OFFICER
—
$23.80M (74) scheduled
−$23.80M
4,680,959
$46.81M
—
ORBIMED ADVISORS LLC entity
Director
$28.10M (3)
$12.59M (5)
+$15.51M
8,740,888
$87.41M
+782.0%
Thompson Peter A.
Director
$28.10M (3)
$12.59M (5)
+$15.51M
8,740,888
$87.41M
+782.0%
Shawver Laura
Director
—
$8.63M (23) scheduled
−$8.63M
210,346
$2.10M
+163.3%
Chakma Justin
Chief Business Officer
—
$8.56M (13) scheduled
−$8.56M
0
$0.00
—
Schroeder Thilo
Director
$5.00M (1)
—
+$5.00M
1,910,029
$19.10M
—
ROOT JONATHAN D
Director
$2.04M (3)
—
+$2.04M
2,269,417
$22.69M
+4.5%
Dorsey Brian
Chief Operating Officer
—
$1.82M (5) scheduled
−$1.82M
10,789
$107.89K
0.0%
SAUNDERS BRENT L
Director
—
$1.71M (1) scheduled
−$1.71M
0
$0.00
—
Karas Eric
Chief Commercial Officer
—
$1.31M (8) scheduled
−$1.31M
12,176
$121.76K
0.0%
Scott Kathleen D.
Chief Financial Officer
$51.51K (1)
$1.29M (4) scheduled
−$1.24M
18,292
$182.92K
+82.2%
Fitzpatrick Alexander A
Chief Legal Officer
$319.95K (2)
$1.49M (2) scheduled
−$1.17M
90,910
$909.10K
+728.3%
Presidio Management Group XII, L.L.C. entity
10% owner
$1,000.00K (1)
—
+$1,000.00K
2,221,798
$22.22M
—
Piazza Jonathan
Chief Financial Officer
$249.98K (1)
—
+$249.98K
69,225
$692.25K
+2,809%
CAPPS VICKIE L
Director
$199.98K (1)
—
+$199.98K
61,576
$615.76K
+18.3%
Hawkinson Russ
Sr. Vice President of Finance
$5.00K (1)
—
+$5.00K
37,251
$372.51K
+3,062%
Shah Pratik
Director
—
—
—
4,474,554
$44.75M
—
Dadoo Rajeev
Director
—
—
—
3,009,677
$30.10M
—
Alexandria Venture Investments, LLC entity
10% owner
—
—
—
699,412
$6.99M
—
Kelly Michael
Director
—
—
—
83,225
$832.25K
—
Odegard Valerie
President and CSO
—
—
—
61,639
$616.39K
—
Hunder Naomi
Chief Medical Officer
—
—
—
54,427
$544.27K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
Flynn James E
27 Jun 2025
10% owner
Sell indirect
370,074
$18.46
$6.83M
Flynn James E
27 Jun 2025
10% owner
Sell indirect
370,075
$18.46
$6.83M
Chakma Justin
27 Nov 2024
Chief Business Officer
Sell
25,000
$14.39
$359.75K
Chakma Justin
26 Nov 2024
Chief Business Officer
Sell
42,186
$14.05
$592.57K
Chakma Justin
25 Nov 2024
Chief Business Officer
Sell
32,814
$14.00
$459.42K
Flynn James E
12 Nov 2024
10% owner
Sell indirect
9,553
$17.77
$169.76K
Flynn James E
12 Nov 2024
10% owner
Sell indirect
9,554
$17.77
$169.77K
Flynn James E
12 Nov 2024
10% owner
Sell indirect
7,854
$17.16
$134.77K
Flynn James E
12 Nov 2024
10% owner
Sell indirect
7,853
$17.16
$134.76K
Flynn James E
11 Nov 2024
10% owner
Sell indirect
223,632
$18.15
$4.06M
Flynn James E
11 Nov 2024
10% owner
Sell indirect
223,632
$18.15
$4.06M
Flynn James E
11 Nov 2024
10% owner
Sell indirect
40,596
$17.45
$708.40K
Flynn James E
11 Nov 2024
10% owner
Sell indirect
40,596
$17.45
$708.40K
ORBIMED ADVISORS LLC
26 Aug 2024
Director
Sell indirect
83,695
$13.00
$1.09M
Thompson Peter A.
26 Aug 2024
Director
Sell indirect
83,695
$13.00
$1.09M
ORBIMED ADVISORS LLC
23 Aug 2024
Director
Sell indirect
69,500
$13.03
$905.59K
Thompson Peter A.
23 Aug 2024
Director
Sell indirect
69,500
$13.03
$905.59K
ORBIMED ADVISORS LLC
22 Aug 2024
Director
Sell indirect
391,482
$12.94
$5.07M
Thompson Peter A.
22 Aug 2024
Director
Sell indirect
391,482
$12.94
$5.07M
ORBIMED ADVISORS LLC
21 Aug 2024
Director
Sell indirect
13,300
$14.61
$194.31K
ORBIMED ADVISORS LLC
21 Aug 2024
Director
Sell indirect
394,400
$13.52
$5.33M
Thompson Peter A.
21 Aug 2024
Director
Sell indirect
13,300
$14.61
$194.31K
Thompson Peter A.
21 Aug 2024
Director
Sell indirect
394,400
$13.52
$5.33M
Showing 250 of 261 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 229
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 149
Sales straight out of an exercise 51
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 84,407,624
History held since 7 Dec 2020